Corrigendum to: Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application (Aging Cell, (2017), 16, 5, (1083-1093), 10.1111/acel.12635);Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application

Aging Cell

Volumn 16, Issue 5, 2017, Pages 1083-1093

  Zhao, Pan ^a,b   Sui, Bing Dong ^a   Liu, Nu ^a,c   Lv, Ya Jie ^a,d   Zheng, Chen Xi ^a   Lu, Yong Bo ^b   Huang, Wen Tao ^b   Zhou, Cui Hong ^a,b   Chen, Ji ^a   Pang, Dan Lin ^a   Fei, Dong Dong ^a   Xuan, Kun ^a   Hu, Cheng Hu ^a,b   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Institute for Tissue Engineering and Regenerative Medicine Research of Xi'an   (China)

^c ZUNYI MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

aged skin; AMPK pathway; anti aging pharmacology; metformin; vascularization; wound healing

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; CD31 ANTIGEN; COLLAGEN; CYCLIN D1; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; RAPAMYCIN; RESVERATROL; S6 KINASE; SIRTUIN 1; CCND1 PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, RAT; S6K1 PROTEIN, RAT; STILBENE DERIVATIVE;

AGING; AMPK SIGNALING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; FEMALE; GENE EXPRESSION; GRANULATION TISSUE; HAIR FOLLICLE; LOCAL THERAPY; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SKIN APPENDAGE; SKIN INJURY; UPREGULATION; VASCULARIZATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANIMAL; BLUNT TRAUMA; CUTANEOUS DRUG ADMINISTRATION; CUTANEOUS PARAMETERS; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INJURIES; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN; SPRAGUE DAWLEY RAT;

ACETYL-COA CARBOXYLASE; ADMINISTRATION, CUTANEOUS; AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; METFORMIN; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES; SIROLIMUS; SKIN; SKIN AGING; STILBENES; TUMOR SUPPRESSOR PROTEIN P53; WOUND HEALING; WOUNDS, NONPENETRATING;

EID: 85021741701     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.13561     Document Type: Erratum

References (45)

1. An Y, Wei W, Jing H, Ming L, Liu S, Jin Y (2015) Bone marrow mesenchymal stem cell aggregate: an optimal cell therapy for full-layer cutaneous wound vascularization and regeneration. Sci. Rep. 5, 17036.
2. Baraka AM, Deif MM (2011) Role of activation of 5′-adenosine monophosphate-activated protein kinase in gastric ulcer healing in diabetic rats. Pharmacology 88, 275–283.
3. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA (2016) Metformin as a tool to target aging. Cell Metab. 23, 1060–1065.
4. Blagosklonny MV (2008) Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells. Rejuvenation Res. 11, 801–808.
5. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ III, Holtzin L, Schultz GS, Jurkiewicz MJ, Lynch JB (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med. 321, 76–79.
6. Cai N, Dai SD, Liu NN, Liu LM, Zhao N, Chen L (2012) PI3K/AKT/mTOR signaling pathway inhibitors in proliferation of retinal pigment epithelial cells. Int. J. Ophthalmol. 5, 675–680.
7. Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, Tamakloe T, Chu WM, Guan KL, Wan Y (2008) AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J. Biol. Chem. 283, 28897–28908.
8. Checkley LA, Rho O, Moore T, Hursting S, DiGiovanni J (2011) Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Prev. Res. 4, 1011–1020.
9. Chen Y, Tseng SH (2007) Review. Pro- and anti-angiogenesis effects of resveratrol. In vivo 21, 365–370.
10. Chen N, Sui BD, Hu CH, Cao J, Zheng CX, Hou R, Yang ZK, Zhao P, Chen Q, Yang QJ, Jin Y, Jin F (2016) microRNA-21 contributes to orthodontic tooth movement. J. Dent. Res. 95, 1425–1433.
11. Dallaglio K, Bruno A, Cantelmo AR, Esposito AI, Ruggiero L, Orecchioni S, Calleri A, Bertolini F, Pfeffer U, Noonan DM, Albini A (2014) Paradoxic effects of metformin on endothelial cells and angiogenesis. Carcinogenesis 35, 1055–1066.
12. Eguchi G, Eguchi Y, Nakamura K, Yadav MC, Millan JL, Tsonis PA (2011) Regenerative capacity in newts is not altered by repeated regeneration and ageing. Nat. Commun. 2, 384.
13. Fontana L, Partridge L (2015) Promoting health and longevity through diet: from model organisms to humans. Cell 161, 106–118.
14. George J, Singh M, Srivastava AK, Bhui K, Roy P, Chaturvedi PK, Shukla Y (2011) Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53. PLoS ONE 6, e23395.
15. Girbovan C, Kent P, Merali Z, Plamondon H (2016) Dose-related effects of chronic resveratrol administration on neurogenesis, angiogenesis, and corticosterone secretion are associated with improved spatial memory retention following global cerebral ischemia. Nutr. Neurosci. 19, 352–368.
16. Hofman D, Moore K, Cooper R, Eagle M, Cooper S (2007) Use of topical corticosteroids on chronic leg ulcers. J. Wound Care 16, 227–230.
17. Johnson KE, Wilgus TA (2014) Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv. Wound Care 3, 647–661.
18. Lamming DW, Ye L, Sabatini DM, Baur JA (2013) Rapalogs and mTOR inhibitors as anti-aging therapeutics. J. Clin. Invest. 123, 980–989.
19. Leontieva OV, Paszkiewicz GM, Blagosklonny MV (2014) Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet. Aging Cell 13, 616–622.
20. Li P, Liang ML, Zhu Y, Gong YY, Wang Y, Heng D, Lin L (2014) Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts. World J. Gastroenterol. 20, 4648–4661.
21. Liu S, Jiang L, Li H, Shi H, Luo H, Zhang Y, Yu C, Jin Y (2014a) Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J. Invest. Dermatol. 134, 2648–2657.
22. Liu Y, Tang G, Zhang Z, Wang Y, Yang GY (2014b) Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neurosci. Lett. 579, 46–51.
23. Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, Jurczak MJ, Camporez JP, Lee HY, Cline GW, Samuel VT, Kibbey RG, Shulman GI (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542–546.
24. Mills RE, Taylor KR, Podshivalova K, McKay DB, Jameson JM (2008) Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice. J. Immunol. 181, 3974–3983.
25. Ochoa-Gonzalez F, Cervantes-Villagrana AR, Fernandez-Ruiz JC, Nava-Ramirez HS, Hernandez-Correa AC, Enciso-Moreno JA, Castañeda-Delgado JE (2016) Metformin induces cell cycle arrest, reduced proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS ONE 11, e0150900.
26. Olbrich KC, Meade R, Bruno W, Heller L, Klitzman B, Levin LS (2005) Halofuginone inhibits collagen deposition in fibrous capsules around implants. Ann. Plast. Surg. 54, 293–296; discussion 296.
27. Ouchi N, Shibata R, Walsh K (2005) AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ. Res. 96, 838–846.
28. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421–433.
29. Reed MJ, Penn PE, Li Y, Birnbaum R, Vernon RB, Johnson TS, Pendergrass WR, Sage EH, Abrass IB, Wolf NS (1996) Enhanced cell proliferation and biosynthesis mediate improved wound repair in refed, caloric-restricted mice. Mech. Ageing Dev. 89, 21–43.
30. Reinke JM, Sorg H (2012) Wound repair and regeneration. Eur. Surg. Res. 49, 35–43.
31. Sgonc R, Gruber J (2013) Age-related aspects of cutaneous wound healing: a mini-review. Gerontology 59, 159–164.
32. Sharples AP, Hughes DC, Deane CS, Saini A, Selman C, Stewart CE (2015) Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell 14, 511–523.
33. Shaw TJ, Martin P (2009) Wound repair at a glance. J. Cell Sci. 122(Pt 18), 3209–3213.
34. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, Keyes WM (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119–1130.
35. Sui B, Hu C, Jin Y (2016a) Mitochondrial metabolic failure in telomere attrition-provoked aging of bone marrow mesenchymal stem cells. Biogerontology 17, 267–279.
36. Sui B, Hu C, Zhang X, Zhao P, He T, Zhou C, Qiu X, Chen N, Zhao X, Jin Y (2016b) Allogeneic mesenchymal stem cell therapy promotes osteoblastogenesis and prevents glucocorticoid-induced osteoporosis. Stem Cells Transl. Med. 5, 1238–1246.
37. Sui BD, Hu CH, Zheng CX, Shuai Y, He XN, Gao PP, Zhao P, Li M, Zhang XY, He T, Xuan K, Jin Y (2017) Recipient glycemic micro-environments govern therapeutic effects of mesenchymal stem cell infusion on osteopenia. Theranostics 7, 1225–1244.
38. Sun X, Yang Q, Rogers CJ, Du M, Zhu MJ (2017) AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression. Cell Death Differ. 24, 819–831.
39. Vaiserman AM, Lushchak OV, Koliada AK (2016) Anti-aging pharmacology: promises and pitfalls. Ageing Res. Rev. 31, 9–35.
40. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA, Miller RA (2012) Rapamycin slows aging in mice. Aging Cell 11, 675–682.
41. Wu CL, Qiang L, Han W, Ming M, Viollet B, He YY (2013) Role of AMPK in UVB-induced DNA damage repair and growth control. Oncogene 32, 2682–2689.
42. Xing W, Guo W, Zou CH, Fu TT, Li XY, Zhu M, Qi JH, Song J, Dong CH, Li Z, Xiao Y, Yuan PS, Huang H, Xu X (2015) Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway. J. Dermatol. Sci. 79, 101–109.
43. Yang K, Chi H (2015) AMPK helps T cells survive nutrient starvation. Immunity 42, 4–6.
44. Yu GT, Bu LL, Zhao YY, Liu B, Zhang WF, Zhao YF, Zhang L, Sun ZJ (2014) Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma. Am. J. Cancer Res. 4, 764–775.
45. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–1174.